Abstract
Hair loss in alopecia areata is associated with an inflammatory infiltrate of lymphocytes, suggesting an autoimmune cause. In search of a safe and effective treatment option for this condition, researchers enrolled nine patients in a trial of oral psoralen and ultraviolet A (PUVA) therapy plus oral prednisolone for alopecia areata. Six patients had alopecia totalis, and three had alopecia universalis. All patients had …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
